Vast Deal Adds UK Angle to Human Spaceflight Plans

The UK Space Agency has signed a memorandum of understanding with Vast Space, the Colorado-based developer of Haven-1, a commercial orbital station designed to serve as a hub for human spaceflight, scientific research, and industrial manufacturing in low-Earth orbit. The agreement represents a strategic shift in UK space policy, positioning Britain to access privately operated orbital infrastructure and participate in the next generation of human spaceflight missions—a capability the UK has lacked since the closure of government-funded astronaut programmes in the 1990s.

Haven-1, scheduled for orbital deployment in 2027, will offer UK researchers, astronauts, and industry partners direct access to microgravity environments without dependency on traditional governmental space programmes or limited seats aboard national cargo missions. This deal aligns with the UK government's broader ambition to establish Britain as a leader in commercial space technology and expand UK participation in human spaceflight science.

For Scotland's emerging space sector, the Vast partnership signals deeper integration with transatlantic commercial space networks and reinforces the role of UK launch infrastructure—including SaxaVord Spaceport in Shetland—in supporting both cargo and crew logistics for future missions.

Haven-1: The Commercial Station Reshaping Low-Earth Orbit Access

Haven-1 is a single-module commercial space station under development by Vast, a company founded by former SpaceX engineer Omar Hamaout and focused on making space industrially viable. Unlike the International Space Station, which serves government-led science missions and is set to be deorbited around 2030, Haven-1 is purpose-built for commercial operators, private astronauts, government-funded researchers, and industrial partners.

The station will feature a large pressurised module, robotic arms for manufacturing, and docking ports for visiting vehicles. Vast has already secured partnerships with SpaceX (Dragon docking) and other launch providers, and the company is targeting mid-2027 for orbital insertion via a SpaceX Falcon 9 launch.

Key features of Haven-1 include:

  • Continuous occupancy: Designed to support multi-week crewed missions with up to four people at a time.
  • Microgravity manufacturing: Dedicated slots for pharmaceutical, semiconductor, and materials science experiments leveraging weightlessness.
  • Open-access docking: Compatible with multiple spacecraft providers, not limited to a single nation's capabilities.
  • Government research partnerships: Slots reserved for national space agencies and academic institutions.
  • Commercial crew rotations: Regular crew changes via commercial spacecraft, with pricing models negotiated by mission type.

For the UK, Haven-1 represents a pragmatic solution to a long-standing gap: Britain has had no independent human spaceflight capability since the late 1970s and has relied on ESA (European Space Agency) partnerships and limited NASA crew opportunities. The Vast MoU signals a shift toward commercial reliance without surrendering UK strategic interests in human spaceflight science.

UK Space Agency Strategy: Filling the Post-ISS Vacuum

The International Space Station is scheduled for controlled deorbit in 2030–2031, leaving a five-to-ten-year window during which international microgravity research capacity will be severely constrained. The UK, via the UK Space Agency, has been exploring options to maintain access to human spaceflight research platforms. The Vast MoU is one element of a broader strategy that also includes engagement with Axiom Space (building a commercial segment attached to ISS before its deorbit) and Chinese and private international platforms.

Dr. Frank Phipps, Director of Spaceflight and Future Missions at the UK Space Agency, stated in recent industry briefings that the agency is prioritising partnerships that:

  • Provide continuous UK researcher access to microgravity environments post-2031.
  • Enable UK-led scientific missions aligned with national research priorities (life sciences, materials, manufacturing, fundamental physics).
  • Support UK commercial sector participation, including satellite operators and materials suppliers.
  • Build capability for UK astronaut missions, enhancing national space prestige and STEM engagement.

The Vast partnership satisfies these criteria by offering reserved research slots, guaranteed crew access for UK astronauts, and open commercial terms that UK companies can negotiate individually.

Under the MoU framework, the UK Space Agency is expected to:

  • Fund or co-fund UK research missions to Haven-1 via existing grants and the UK Space Exploration Grants Scheme.
  • Nominate UK astronauts for crewed missions, pending training agreements with Vast and SpaceX (Dragon).
  • Coordinate with UK academic and industrial partners to develop science payloads.
  • Support regulatory pathways for UK crew and cargo via the Civil Aviation Authority (CAA) and UK licensing frameworks.

UK Astronaut Participation: Reclaiming Human Spaceflight Heritage

One of the most symbolically significant aspects of the Vast deal is the pathway it creates for UK astronaut missions. The UK has a rich history of human spaceflight: Helen Sharman flew on Soyuz to Mir in 1991, and Piers Sellers and Tim Peake completed long-duration missions on ISS. However, post-Tim Peake (who returned from ISS in 2016), the UK has had no active astronaut flight schedule or government-funded seats on commercial vehicles.

The UK Space Agency currently maintains a cadre of astronauts, including Tim Peake, Rosalind Luthi (ESA astronaut corps), and others in development roles. Haven-1 missions would provide opportunities for:

  • Short-duration missions (7–14 days): Scientific experiments, station maintenance, technology demonstrations.
  • Long-duration missions (30+ days): Research leadership roles, external activities, and crew rotation duties.
  • Private astronaut missions: Self-funded or corporate-sponsored flights, expanding the pool beyond government-selected candidates.

The commercial model also lowers barriers to entry compared to traditional government astronaut selection: rather than a single highly competitive UK programme, multiple pathways exist—government-funded science missions, corporate sponsorship, and private ticket sales through commercial crew operators.

Scotland's Spaceport Role in Commercial Human Spaceflight Logistics

While Haven-1 will be launched from US soil via SpaceX, the infrastructure supporting UK crew and cargo logistics could eventually involve Scottish facilities. SaxaVord Spaceport, located on Unst in the Shetland Isles, is licensed for vertical launch of small satellites and is now exploring applications for microgravity research payloads and potential cargo missions to commercial stations.

Additionally, Prestwick Spaceport and Glasgow-based companies like Clyde Space are developing satellite and payload infrastructure that could support Haven-1 missions. UK-built smallsats and experiment modules may eventually fly to Haven-1 via various launch providers, creating a closed-loop ecosystem where Scottish design and manufacturing feed into crewed missions.

The Vast deal also reinforces the case for horizontal launch and spaceport infrastructure in Scotland: if UK crew missions become routine, demand for crew rotation vehicles, emergency rescue assets, and support logistics could drive long-term spaceport business models beyond pure satellite launch.

Scientific and Economic Implications for UK Research

Access to Haven-1 opens new possibilities for UK-led research in several high-value domains:

Life Sciences and Pharmaceuticals

UK universities and biotech firms have world-leading capabilities in protein crystal growth, organ-on-chip development, and gravitational biology. Microgravity environments accelerate drug discovery by enabling unique molecular structures impossible to create on Earth. Companies like Oxford Biomedica and Cambridge-based firms have expressed interest in orbital manufacturing trials; Haven-1 provides an operational platform without ISS scheduling constraints.

Materials Science and Manufacturing

Metals, ceramics, and specialty alloys exhibit novel properties when solidified in microgravity. UK metallurgy and manufacturing research groups (supported by the Engineering and Physical Sciences Research Council, EPSRC) have proposed experiments on advanced composites, lattice materials, and rare-earth processing. Haven-1 offers dedicated microgravity furnace time at predictable costs.

Fundamental Physics and Space-Based Technology

The UK has leadership in quantum sensing, atomic clocks, and precision measurement. Microgravity instruments are key to next-generation gravitational wave detectors and fundamental constants experiments. Several UK research councils (STFC, NERC) have identified human-tended orbital platforms as critical to maintaining UK competitiveness in 21st-century physics.

Economically, the Vast partnership is expected to generate:

  • Research revenue: UK universities and research institutions billing ESA, UK Space Agency, and private sponsors for mission design, payload development, and data analysis.
  • Industrial procurement: Experiment modules, subsystems, and support equipment purchased from UK manufacturers.
  • Skills and STEM engagement: Crew training, payload operations, and public outreach associated with UK astronaut flights.
  • Competitive advantage: UK firms developing microgravity-optimised products (pharmaceuticals, advanced materials) can access faster development cycles via Haven-1 compared to traditional ISS queues.

Regulatory and Policy Framework: The UK Space Industry Act 2018 and Beyond

The Vast MoU sits within the broader regulatory landscape established by the UK Space Industry Act 2018, which grants the Civil Aviation Authority (CAA) authority to license and regulate commercial space activities, including crewed launches and orbital operations. Key regulatory elements supporting the Vast deal include:

  • Export control licensing: UK technology and crew exported to US-launched missions must comply with International Traffic in Arms Regulations (ITAR) and UK Export Control Order 2008. The Vast partnership likely triggers coordinated licensing between the CAA, Department for Business and Trade, and US State Department.
  • Crew welfare and safety standards: The CAA is developing crewed commercial spaceflight licensing frameworks aligned with international standards. UK astronauts flying on Haven-1 will be subject to UK and international safety oversight.
  • Data and IP protection: Research data generated on Haven-1 by UK-funded missions will be governed by UK government data protection policies and research council regulations (EPSRC, STFC), with negotiated access and publication rights.
  • Environmental compliance: Haven-1 deorbit planning and debris mitigation must meet UK and international space debris guidelines.

The UK Space Agency is expected to publish supplementary guidance on Haven-1 mission procurement and crew nomination criteria by Q4 2026, aligning with Vast's 2027 launch schedule.

Competitive Landscape: Axiom, Orbital Reef, and International Alternatives

The Vast MoU does not preclude UK engagement with other commercial station developers. Axiom Space is building the Axiom Station, initially attached to ISS and later free-flying post-2030. The UK has informal partnerships with Axiom and is exploring co-funded research missions. Orbital Reef (Blue Origin / Sierra Space joint venture) is another contender, though development timelines are uncertain.

Internationally, the European Space Agency is developing the European Space Exploration Programme, which includes partnerships with Axiom and Chinese commercial platforms. The UK, post-Brexit, is pursuing a hybrid strategy: ESA collaboration where advantageous, bilateral partnerships (like Vast) where commercially beneficial, and independent capabilities (SaxaVord, UK launch) where strategically important.

The Vast deal signals UK confidence in the commercial space sector and willingness to bet on private stations over state-led alternatives—a pragmatic choice given budgetary constraints and the competitive pace of commercial space development.

Timeline and Next Steps: 2026–2028 Outlook

Based on publicly available information and industry briefings, the following timeline is expected:

  • Q4 2026: UK Space Agency publishes formal Haven-1 partnership guidelines and opens calls for research mission proposals.
  • Q1–Q2 2027: Haven-1 launches aboard SpaceX Falcon 9; initial checkout and crew arrival via Dragon. UK research payloads begin loading into cargo manifest.
  • 2027–2028: First UK government-funded science missions to Haven-1; potential UK astronaut nomination and crew rotation planning.
  • 2028+: Routine UK research and commercial missions; potential expansion to longer-duration UK crew assignments.

Key milestones to monitor include:

  • Vast's secure funding for Haven-1 full development (as of September 2026, the company had announced $500M+ in private investment but government participation remains under discussion).
  • SpaceX launch manifest confirmation and schedule stability.
  • UK crew member selection and ESA/international astronaut corps coordination.
  • CAA crewed commercial spaceflight licensing finalisation.
  • UK research proposal outcomes and payload development timelines.

Forward-Looking Analysis: Strategic Implications for UK Space Ambitions

The Vast MoU represents a significant inflection point in UK space strategy. Rather than pursuing an independent human spaceflight programme (politically and financially unrealistic for Britain), the government is leveraging commercial innovation to maintain strategic presence in human spaceflight research and establish UK-branded astronaut participation.

Strategic benefits:

  • Cost efficiency: Shared commercial infrastructure is far cheaper than standalone national programmes. UK contributions are estimated at £10–20M annually, compared to £500M+ for independent station development.
  • Rapid capability: Haven-1 is operational in 2027, years before traditional government efforts could mature. This accelerates UK re-entry into human spaceflight.
  • Research continuity: Post-ISS deorbit, Haven-1 provides seamless access to microgravity research for UK scientists and industry.
  • Soft power: UK astronauts and research missions garner global prestige and media attention, supporting STEM engagement and national branding.
  • Ecosystem resilience: Multiple partnerships (Vast, Axiom, ESA, others) reduce UK dependency on any single provider.

Risks and challenges:

  • Commercial viability: If Vast or other commercial stations face financial difficulties or launch delays, UK research plans could be disrupted. Long-term sustainability of commercial orbital infrastructure remains unproven.
  • Regulatory uncertainty: International crewed spaceflight remains heavily regulated; delays in CAA licensing or export control approvals could impact mission timelines.
  • Supply chain dependency: UK relies on US launch providers (SpaceX) and international crew systems (Dragon). Geopolitical tensions or sanctions could disrupt access.
  • Budget competition: Competing demands on UK Space Agency funding (satellite constellations, Earth observation, ground infrastructure) may limit resources available for Haven-1 research missions.

Scotland's role:

While Haven-1 launches from the US, Scotland's spaceport infrastructure and space industry are positioned to support downstream logistics, payload development, and crew operations. SaxaVord and other Scottish launch sites may eventually host:

  • Smallsat constellations for Earth observation and comms supporting Haven-1 missions.
  • Microgravity experiment modules designed and manufactured in Scotland.
  • Crew training facilities or simulation centres supporting UK astronauts.
  • Horizontal spaceplane operations for crew rotation (if future commercial development permits).

The Vast partnership thus reinforces Scotland's emerging role as part of the broader UK space ecosystem, connecting northern European launch infrastructure to transatlantic human spaceflight networks.

Conclusion: A New Era for UK Human Spaceflight

The UK Space Agency's memorandum of understanding with Vast Space marks the beginning of a new chapter in British human spaceflight. For four decades, the UK has been absent from crewed missions; the Vast partnership offers a credible, cost-effective pathway to restore UK presence in human spaceflight research, astronaut participation, and orbital science. Haven-1, launching in 2027, will serve as a flagship platform for UK researchers, astronauts, and industry partners—bridging the gap between the ISS era and the next generation of commercial orbital infrastructure.

For Scotland, the deal reinforces the importance of spaceport infrastructure, payload development, and supply chain integration within the wider UK space sector. As commercial human spaceflight becomes routine, Scotland's role in supporting crew logistics, research facilities, and manufacturing will deepen, creating high-value jobs and positioning the nation as a key node in transatlantic space networks.

The Vast deal is a pragmatic, forward-looking investment in UK space ambitions—one that acknowledges the limits of government programmes while embracing the opportunities of commercial innovation and international partnership.